UY38301A - Cannabidiol soluble en agua - Google Patents

Cannabidiol soluble en agua

Info

Publication number
UY38301A
UY38301A UY0001038301A UY38301A UY38301A UY 38301 A UY38301 A UY 38301A UY 0001038301 A UY0001038301 A UY 0001038301A UY 38301 A UY38301 A UY 38301A UY 38301 A UY38301 A UY 38301A
Authority
UY
Uruguay
Prior art keywords
cannabidiol
water
soluble
cyclodextrin
hydroxypropylated
Prior art date
Application number
UY0001038301A
Other languages
English (en)
Inventor
Krishna Mallia Anantha
W House David
Rajaram Oroskar Anil
Anil Oroskar Asha
Original Assignee
Orochem Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orochem Tech Inc filed Critical Orochem Tech Inc
Publication of UY38301A publication Critical patent/UY38301A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Abstract

Se proporciona una composición para consumo oral que comprende (a) ß-ciclodextrina metilada y/o ß-ciclodextrina hidroxipropilada, (b) cannabidiol, y (c) agua. También se proporciona un método para formar una composición para consume oral que comprende (a) ß-ciclodextrina metilada y/o ß-ciclodextrina hidroxipropilada, (b) cannabidiol, y (c) agua.
UY0001038301A 2018-07-16 2019-07-16 Cannabidiol soluble en agua UY38301A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/036,271 US20200016091A1 (en) 2018-07-16 2018-07-16 Water-soluble cannabidiol

Publications (1)

Publication Number Publication Date
UY38301A true UY38301A (es) 2020-01-31

Family

ID=67480416

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038301A UY38301A (es) 2018-07-16 2019-07-16 Cannabidiol soluble en agua

Country Status (4)

Country Link
US (1) US20200016091A1 (es)
TW (1) TW202010490A (es)
UY (1) UY38301A (es)
WO (1) WO2020018453A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020028198A1 (en) 2018-08-03 2020-02-06 Biomass Oil Separation Solutions, Llc Processes and apparatus for extraction of substances and enriched extracts from plant material
US11972811B2 (en) 2018-11-18 2024-04-30 NEO Semiconductor, Inc. Methods and apparatus for NAND flash memory
US10799546B1 (en) 2019-07-26 2020-10-13 Biomass Oil Separation Solutions, Llc Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material
US11975098B2 (en) 2020-05-22 2024-05-07 Colorado School Of Mines Nanosuspensions of cannabidiol for developing water-dispersible formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20020333A0 (fi) * 2002-02-20 2002-02-20 Tomi Jaervinen Metyloidun syklodekstriinin uudet kompleksit
WO2017183011A1 (en) * 2016-04-22 2017-10-26 Degeeter David M Water soluble cannabinoid inclusion complexes

Also Published As

Publication number Publication date
US20200016091A1 (en) 2020-01-16
WO2020018453A1 (en) 2020-01-23
TW202010490A (zh) 2020-03-16

Similar Documents

Publication Publication Date Title
UY38301A (es) Cannabidiol soluble en agua
CL2016001544A1 (es) Composición dentífrica que comprende óxido de zinc y citrato de zinc
AR096109A1 (es) Bolsa que comprende una composición detergente líquida
PE20040895A1 (es) Formulacion de complejo de aripiprazol
UY30109A1 (es) Formas farmacológicas en forma de película para usar en la cavidad bucal (obleas)
CL2012003625A1 (es) Una composicion acuosa que contiene bromhexina, en donde la composicion tiene una cantidad de azucar-alcoholes inferior a 10 g referida a 100 ml de la composicion; y su uso para la terapia secretorica en enfermedades broncopulmonares agudas y cronicas.
CR20150639A (es) Derivados de benzimidazol como inhbidores de bromodominio
CL2015000574A1 (es) Formulaciones acuosas estables de adalimumab.
CL2016001547A1 (es) Composiciones para el cuidado oral
BR112016007358A2 (pt) bloco bruto para usinagem de próteses dentárias
CU20100230A7 (es) Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
CL2011002716A1 (es) Aspa de turbina direccional que incluye una raiz de aspa y una punta de aspa, una primera cara y una segunda cara que se extienden entre la raiz del aspa yla punta del aspa, cuyo perfil de seccion transversal es simetrico, respecto de una linea de cuerda generada entre los bordes del aspa ; metodo para impulsar una turbina submarina; y turbina submarina.
AR113901A1 (es) Uso tópico y entrega de microorganismos oxidantes de amoniaco
AR100050A1 (es) Proceso para acidificación usando formulaciones ácidas retardadas
BR112013013900A2 (pt) composição, uso de um éter polissacarídeo linear hidroxílico de alquila inferior hidrofobicamente modificado não iônico solúvel em água, método para o tratamento de uma planta e método para melhorar a deposição, sobre uma planta, de uma composição aquosa
CO6400190A2 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma
ECSP21026021A (es) Moduladores de la expresión de pnpla3
NAYELLI Hallyu y su impacto en la sociedad mexicana
BR112017008670A2 (pt) película oral de dexametasona
AR098888A1 (es) Composición para el cuidado oral
CO6700840A2 (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia
BR112012009150A2 (pt) pneumático tendo uma banda de rodagem e um ressalto
UY38829A (es) Cannabinoides solubles en agua
CO2021016775A2 (es) Método de riego que utiliza hidrogeles en el suelo para extraer agua de la atmosfera
CL2019000174A1 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d.